SiO/sub 2/-Si/sub 3/N/sub 4/
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... In this study, all the mice were successfully developed into subcutaneously transplanted tumor models. When the diam- eter of subcutaneously transplanted tumor reached 1.0 cm, nine mice were divided into three groups ...
13
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... Nag, N-acetylglutamate; Nas, N-acetyl glycoprotein signal; N-Mh, N-methylnicotinamide; NP, neopterin; o-hPa, ortho-hydroxyphenylacetate; Pa, picolinate; Pag, phenylacetylglycine; Pan, ...
16
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... Fe 3 O 4 @SiO 2 nanoparticles with high doxorubicin (DOX) loading (TfDMP), for dual targeting of cancer, by chemically coupling both Tf and DOX with dual-function magnetic nanoparticles (DMPs) ...
9
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... Fe 3 O 4 @SiO 2 , which allows high efficient loading of VEGF small hairpin (sh)RNA to form Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA nanocomposites for VEGF gene silencing ...
13
Decreased bacteria activity on Si<sub>3</sub>N<sub>4</sub> surfaces compared with PEEK or titanium
... nm, 3 nm, and 1 nm for the as- fired Si 3 N 4 , polished Si 3 N 4 , Ti, and PEEK, ...of Si 3 N 4 is similar to that of Ti and ...
12
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Fe 3 O 4 @ SiO 2 @Ag ...Van/Fe 3 O 4 @SiO 2 @Ag microflowers (Figure 3B and ...Fe 3 O 4 @SiO 2 @Ag microflowers are surrounded by a thin ...
18
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Notes: (A) cell viability of l929 cells incubated with different concentrations (10 µM, 1 µM, and 100 nM) of the gd-NPs for 24 and 48 hours. (B) apoptosis rates of Raw264.7 cells were measured by flow cytometry at 48 ...
11
Effect of Alkaline and Alkaline Earth Metal Oxides Addition on the Glass Formation and Crystallization of ZnO Al<sub>2</sub>O<sub>3</sub> SiO<sub>2</sub> Glasses
... Table 3 and 4. According to Table 3, only 20AZ3Li and 20AZ3Li6T became glasses among samples containing alkaline metal oxides, and the others crystallized and became ...
13
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... aged 4 weeks and weighing 20–22 g were divided into six groups, with 10 mice per group (half male and half ...Fe 3 O 4 , sterile normal saline was added to prepare mixed suspensions of different ...
10
Assessing the axonal translocation of CeO<sub>2</sub> and SiO<sub>2</sub> nanoparticles in the sciatic nerve fibers of the frog: an ex vivo electrophysiological study
... Frogs (Rana ridibunda) of either sex and of the same age (ranging from 12 to 15 months), weighing 40–60 g, were used. The frogs were euthanatized (decapitated and pithed), and the sciatic nerves were dissected from the ...
8
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Fe 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...FeCl 3 injury to the abdominal aorta and at 0 min, 10 min, 20 min, 30 min, 1 h, 2 h, and 3 h after injection of ...
14
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... Fe 3 O 4 NPs on I MEP , we studied whether the nanoparticles could alter the I MEP measured at the different levels of membrane potentials in these ...Figure 2 shows the I–V relations obtained in the ...
10
Cytokine induction of sol–gel-derived TiO<sub>2</sub> and SiO<sub>2</sub> coatings on metallic substrates after implantation to rat femur
... (TiO 2 ) and silica (SiO 2 ) coatings prepared by sol–gel ...TiO 2 or SiO 2 coatings reduced significantly the production of proinflammatory cytokines by local tissues, ...
7
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... O n -SiO 2 composite flake-like, and SiO 2 -Fe m O n core-shell IONPs on cell viability, function, and mor- phology were tested 48 h postincubation in human umbilical vein ...
11
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... approach for reducing the total cost of electricity generation [5-7]. It is well established that the use of suitable catalyst at the electrode of SOFC is the key issue for achieving the good SOFC cogeneration ...
12
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... China). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro- mide (MTT) and dimethyl sulfoxide were obtained from Sigma-Aldrich (St Louis, ...HAuCl 4 , NH 2 OH 3 HCl, and potassium ...
15
<p>Distribution of SiO<sub>2</sub> nanoparticles in 3D liver microtissues</p>
... 1, 2, 4, and 7) after cell seeding (Figure ...(day 4 and 7), the cell spheroids exhibited a round and more regular ...day 4 the spheroid sizes were about 350 µ ...day 3 and 7, indicated ...
21
Metathesis of Ethylene and Trans 2 Butene over MgO Admixed WO<sub>3</sub>/SiO<sub>2</sub> Catalysts
... The TGA measurements were carried out on the fresh catalysts after exposed in air at room temperature for 3 days and the results are shown Fig. 4. The weight loss of catalysts was found to be in the order: ...
16
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... Mice were randomly assigned to one of four groups (n = 10 per group). The doses of 5.14 mg/kg (low dose group), 20.7 mg/kg (medium dose group), and 51.4 mg/kg (high dose group) Fe 3 O 4 -MNPs, were ...
7
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... day 3 after ...day 3, and thereafter decreased ...Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...day 3 after dosing, indicating that the liver and spleen were ...
6